The damage caused by cirrhosis can’t be undone, however, if the condition is diagnosed early and the underlying cause is ...

First patients dosed in Phase 3 SYNCHRONY Outcomes study of lead candidate efruxifermin (EFX) in patients with compensated ...

Among 64 patients who received immune checkpoint inhibitors, 78% had downstaging of their liver tumor to within Milan ...

The ELF test yielded similar prognostic effectiveness to histologically evaluated fibrosis in predicting clinical outcomes.

Liver biomarkers at baseline in addition to changes during follow-up are associated with cirrhosis and HCC in HDV.

The bacterial changes also correlate with increased antibiotic resistance, highlighting the need for better targeting of ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed ...

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three ...